Actuate Therapeutics Inc.
ACTU
Get informed when a big investor buys or sells
+ FollowMarket Cap$39.6M
Close$
$0.61
60.6% downside
Current Fair Value
60.6% downsideOvervalued by 60.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $39.60 Million |
|---|---|
| Enterprise Value | $35.17 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.06 |
| Beta | 0.78 |
| Outstanding Shares | 23,871,850 |
Return
| Return on Equity | -2067.81% |
|---|---|
| Return on Assets | -393.39% |
| Return on Invested Capital | -1489.99% |
Valuation & Multiples
| P/E Ratio | -1.86 |
|---|---|
| PEG | 10.22 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.69 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$-0.21
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.18
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 58.88%▼ 3.49% |
|---|---|
| Total Invested | $37.97M▼ 52.68% |
| Investors Holding | 61▲ 17.00% |
ESG Score
No data